IL-4 is an important driver in the initiation of lung inflammation in asthma, including Th2 cell proliferation and IgE synthesis [22,23], and high-dose OmeGo significantly reduced IL-4 by 17% (p < 0.05); however, the numeric reduction in serum IgE did not quite achieve significance. Here, IGHE is linked to asthma.